Tag - biopharma

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

Genomenon Completes $5.3M Financing Round

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Sophia Genetics Raises $110 Million In Oversubscribed New Funding Round

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

Genomics England launches next-generation research platform central to UK COVID-19 response

Copyright © 2026. enlighenbio LLC. All rights reserved.